# INTERVIEW: Genedrive Plc Funding to execute commercial strategy

- Link: https://www.directorstalkinterviews.com/interview-genedrive-plc-funding-to-execute-commercial-strategy/412763249
- Published: 2018-12-18T07:03:09+00:00
- Author: Giles Arbor

**Genedrive Plc** (LON:GDR) is the topic of conversation when Hardman & Co, life
sciences Analyst Dr Dorothea Hill talks to DirectorTalk. Dorothea explains the significance
of the recent fundraise, how the proceeds with be used, what stage the technology
is currently at, why she considers the commercial potential of Genedrive technology
so great and thoughts on the current company valuation.

Genedrive plc is a commercial-stage company focused on point-of-care molecular diagnostics.
Its Genedrive(R) molecular diagnostic testing platform is at the forefront of this
technology, offering a rapid, low-cost, simple-to-use device with high sensitivity
and specificity in the diagnosis of infectious diseases. Rapid analysis of patient
samples greatly aids clinical and public health decision-making, with field testing
particularly important in emerging markets. The 2018 fiscal year saw solid operational
progress to generate first commercial sales. CE marking of the assay for hepatitis
C virus (HCV) detection was awarded, and three commercial partnerships were agreed.

Share on: